Company intelligence / Profile preview

Hangzhou Dongye Medical Technology

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

HDMT acts as the exclusive distributor of the LuViva Advanced Cervical Scan—an FDA investigational, non-invasive point-of-care cervical screening device—in Zhejiang Province, China, supporting about two million cervical cancer screenings annually across 42 hospitals. LuViva technology has demonstrated the ability to detect cervical disease up to two years earlier than conventional tests in clinical trials; no proprietary pipeline (HDMT is a distributor, not a product developer).

Therapeutic areas: Oncology
Modalities: Device
Industry: Medical Imaging

Partnerships

Guided Therapeutics (exclusive regional distribution)

Beyond the preview

Go deeper on Hangzhou Dongye Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Dongye Medical Technology.

Explore the full profile